Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma.

Abstract:

:Synovial sarcoma is a soft tissue malignancy characterized by the fusion of SS18 to either SSX1, SSX2, or SSX4 genes. SS18 and SSX are transcriptional cofactors involved in activation and repression of gene transcription, respectively. SS18 interacts with SWI/SNF, whereas SSX associates with the polycomb chromatin remodeling complex. Thus, fusion of these two proteins brings together two opposing effects on gene expression and chromatin structure. Recent studies have shown that a significant number of genes are down-regulated by the SS18-SSX fusion protein and that the clinically applicable histone deacetylase (HDAC) inhibitor romidepsin inhibits synovial sarcoma growth. Therefore, we set out to identify direct targets of SS18-SSX among genes down-regulated in synovial sarcoma and investigated if romidepsin can specifically counteract SS18-SSX-mediated transcriptional dysregulation. Here, we report that the tumor suppressor early growth response 1 (EGR1) is repressed by the SS18-SSX protein through a direct association with the EGR1 promoter. This SS18-SSX binding correlates with trimethylation of Lys(27) of histone H3 (H3K27-M3) and recruitment of polycomb group proteins to this promoter. In addition, we found that romidepsin treatment reverts these modifications and reactivates EGR1 expression in synovial sarcoma cell models. Our data implicate polycomb-mediated epigenetic gene repression as a mechanism of oncogenesis in synovial sarcoma. Furthermore, our work highlights a possible mechanism behind the efficacy of a clinically applicable HDAC inhibitor in synovial sarcoma treatment.

journal_name

Cancer Res

journal_title

Cancer research

authors

Lubieniecka JM,de Bruijn DR,Su L,van Dijk AH,Subramanian S,van de Rijn M,Poulin N,van Kessel AG,Nielsen TO

doi

10.1158/0008-5472.CAN-08-0092

subject

Has Abstract

pub_date

2008-06-01 00:00:00

pages

4303-10

issue

11

eissn

0008-5472

issn

1538-7445

pii

68/11/4303

journal_volume

68

pub_type

杂志文章
  • Retroviral vector-mediated gene transfer of antisense cyclin G1 (CYCG1) inhibits proliferation of human osteogenic sarcoma cells.

    abstract::Genetic changes found in human osteogenic sarcoma cells, including loss of the p53 and Rb tumor suppressor elements and overexpression of the cyclin G1 (CYCG1) proto-oncogene, suggest the potential of gene transfer as a treatment for metastatic disease. In this study, we examined the effects of antisense cyclin G1, in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Skotzko M,Wu L,Anderson WF,Gordon EM,Hall FL

    更新日期:1995-12-01 00:00:00

  • Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

    abstract::The p53-regulated gene product p21WAF1/CIP1 is the prototype of a family of small proteins that negatively regulate the cell cycle. To learn more about p21WAF1/CIP1 regulation in vivo, monoclonal antibodies were developed for immunohistochemistry. These revealed that p21WAF1/CIP1 expression followed radiation-induced ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: el-Deiry WS,Tokino T,Waldman T,Oliner JD,Velculescu VE,Burrell M,Hill DE,Healy E,Rees JL,Hamilton SR

    更新日期:1995-07-01 00:00:00

  • Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation.

    abstract::Deletion of endoplasmic reticulum resident chaperone Grp78 results in activation of the unfolded protein response and causes rapid depletion of the entire intestinal epithelium. Whether modest reduction of Grp78 may affect stem cell fate without compromising intestinal integrity remains unknown. Here, we employ a mode...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3600

    authors: van Lidth de Jeude JF,Spaan CN,Meijer BJ,Smit WL,Soeratram TTD,Wielenga MCB,Westendorp BF,Lee AS,Meisner S,Vermeulen JLM,Wildenberg ME,van den Brink GR,Muncan V,Heijmans J

    更新日期:2018-11-01 00:00:00

  • Hepatic parenchymal cell glutamylation of methotrexate studied in monolayer culture.

    abstract::A detailed analysis of the gamma-glutamylation of methotrexate has been conducted in primary cultures of rat hepatic parenchymal cells in monolayer culture. The rates of glutamylation are concentration dependent and saturable when measured over a 6-h period at concentrations between 2 and 50 microM. The removal of fol...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Galivan J,Pupons A,Rhee MS

    更新日期:1986-02-01 00:00:00

  • Identification of the cross-link between human O6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA.

    abstract::Chloroethylnitrosoureas induce reactive O6-guanine adducts in DNA that can form either interstrand cross-links or a covalent complex with the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT). To test our hypothesis that these end-products are formed from the common precursor, 1-O6-ethanoguanine, we com...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gonzaga PE,Potter PM,Niu TQ,Yu D,Ludlum DB,Rafferty JA,Margison GP,Brent TP

    更新日期:1992-11-01 00:00:00

  • Stimulation of resistance to tumor growth of athymic nude mice pretreated by combined local hyperthermia and X-irradiation.

    abstract::Host resistance to tumor growth was studied in athymic nude mice of C57BL background. Animals were pretreated in the left hind leg by local hyperthermia, local X-irradiation, or combined local hyperthermia and X-irradiation. Twenty-four hr posttreatment, the animals were inoculated with the metastatic Lewis lung carci...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Yerushalmi A,Weinstein Y

    更新日期:1979-03-01 00:00:00

  • An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.

    abstract::Breast cancer has been redefined into three clinically relevant subclasses: (i) estrogen/progesterone receptor positive (ER+/PR+), (ii) HER2/ERRB2 positive, and (iii) those lacking expression of all three markers (triple negative or basal-like). While targeted therapies for ER+/PR+ and HER2+ tumors have revolutionized...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-1098

    authors: McCleland ML,Adler AS,Shang Y,Hunsaker T,Truong T,Peterson D,Torres E,Li L,Haley B,Stephan JP,Belvin M,Hatzivassiliou G,Blackwood EM,Corson L,Evangelista M,Zha J,Firestein R

    更新日期:2012-11-15 00:00:00

  • Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters.

    abstract::The ability of the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), to induce chemotaxis in three different populations of mouse peritoneal macrophages was studied. TPA in the range of 10(-9) to 10(-7) M produced a dose- and time-related increase in chemotaxis in resident, thioglycollate-elicited, and divin...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Laskin DL,Laskin JD,Weinstein IB,Carchman RA

    更新日期:1981-05-01 00:00:00

  • Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands.

    abstract::Epidemiological studies have shown a positive association of colon cancer with hyperlipidemia. Furthermore, signaling generated by peroxisome proliferator-activated receptor (PPAR) alpha and gamma ligands, suggested to be candidate tumor preventive agents, has been shown to lower serum triglyceride levels. In the pres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Niho N,Takahashi M,Kitamura T,Shoji Y,Itoh M,Noda T,Sugimura T,Wakabayashi K

    更新日期:2003-09-15 00:00:00

  • High turnover rate of transfer RNA in tumor tissue.

    abstract::Cancer patients and tumor-bearing animals excrete high levels of modified purines and pyrimidines some of which, e.g., N2,N2-dimethylguanosine, can originate only from transfer RNA (tRNA). Until recently, it could not be ascertained whether the high level of excretion of such compounds is due to cell death or specific...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Borek E,Baliga BS,Gehrke CW,Kuo CW,Belman S,Troll W,Waalkes TP

    更新日期:1977-09-01 00:00:00

  • Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines.

    abstract::Glutamine supplementation has been advocated for patients requiring parenteral nutritional support. However, the direct effect of glutamine on neoplastic cells is poorly understood. We therefore investigated the effects of glutamine on the proliferation, differentiation, and cell-matrix interactions of two human colon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Turowski GA,Rashid Z,Hong F,Madri JA,Basson MD

    更新日期:1994-11-15 00:00:00

  • S100A10 Is a Critical Mediator of GAS6/AXL-Induced Angiogenesis in Renal Cell Carcinoma.

    abstract::Angiogenesis is a hallmark of cancer that promotes tumor progression and metastasis. However, antiangiogenic agents have limited efficacy in cancer therapy due to the development of resistance. In clear cell renal cell carcinoma (ccRCC), AXL expression is associated with antiangiogenic resistance and poor survival. He...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1366

    authors: Xiao Y,Zhao H,Tian L,Nolley R,Diep AN,Ernst A,Fuh KC,Miao YR,von Eyben R,Leppert JT,Brooks JD,Peehl DM,Giaccia AJ,Rankin EB

    更新日期:2019-11-15 00:00:00

  • Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.

    abstract::High doses of 1-beta-D-arabinofuranosylcytosine, administered as a continuous i.v. infusion, were evaluated in a Phase I trial in 14 patients with advanced solid tumors. 1-beta-D-Arabinofuranosylcytosine was given at 250 mg/sq m/h for infusions of 12 to 36 h. The mean steady state 1-beta-D-arabinofuranosylcytosine pla...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spriggs DR,Robbins G,Takvorian T,Kufe DW

    更新日期:1985-08-01 00:00:00

  • Neuroendocrine Transdifferentiation in Human Prostate Cancer Cells: An Integrated Approach.

    abstract::Prostate cancer is highly sensitive to hormone therapy because androgens are essential for prostate cancer cell growth. However, with the nearly invariable progression of this disease to androgen independence, endocrine therapy ultimately fails to control prostate cancer in most patients. Androgen-independent acquisit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3830

    authors: Cerasuolo M,Paris D,Iannotti FA,Melck D,Verde R,Mazzarella E,Motta A,Ligresti A

    更新日期:2015-08-01 00:00:00

  • Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.

    abstract::Human breast cancer (HBC) cell growth suppression by okadaic acid (OA) was previously found to involve elevated expression of oncogenes c-myc and c-fos and apoptosis. Since, c-Myc influences diverse pathways of cell growth, we hypothesized that elevated levels of c-Myc are involved in HBC growth suppression. Here, we ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-2505

    authors: Zhang L,Wali A,Ramana CV,Rishi AK

    更新日期:2007-11-01 00:00:00

  • Hypoxanthine concentrations in normal subjects and patients with solid tumors and leukemia.

    abstract::Mean plasma hypoxanthine (Hyp) concentrations determined by high-pressure liquid chromatography were 0.56 microM (range, 0.2 to 1.9 microM) in 16 normal subjects, 0.68 microM (range, 0.1 to 1.1 microM) in 10 untreated acute leukemic subjects, and 0.89 microM (range, 0.3 to 2.6 microM) in 14 solid tumor patients. Despi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wung WE,Howell SB

    更新日期:1984-07-01 00:00:00

  • Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma.

    abstract::Eighteen-day-old fetal urogenital sinus mesenchyme (UGM), 0-day-old neonatal seminal vesicle mesenchyme (SVM), 0-day-old neonatal bulbourethral gland mesenchyme (BUG-M), and 3-day-old neonatal urinary bladder mesenchyme (BLM) were isolated from rats and combined in vitro with 0.5-mm cubes of the R3327 androgen-depende...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hayashi N,Cunha GR,Wong YC

    更新日期:1990-08-01 00:00:00

  • Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.

    abstract::Chronic inflammation has been hypothesized to be a risk factor for prostate cancer. The Toll-like receptor 4 (TLR4) presents the bacterial lipopolysaccharide (LPS), which interacts with ligand-binding protein and CD14 (LPS receptor) and activates expression of inflammatory genes through nuclear factor-kappaB and mitog...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2078

    authors: Chen YC,Giovannucci E,Lazarus R,Kraft P,Ketkar S,Hunter DJ

    更新日期:2005-12-15 00:00:00

  • Adenoviral E1A function through Myc.

    abstract::The study of DNA tumor viruses has been invaluable in uncovering the cellular nodes and pathways that contribute to oncogenesis. Perhaps one of the best-studied oncoproteins encoded by a DNA tumor virus is adenovirus E1A, which modifies the function of key regulatory proteins such as retinoblastoma (Rb) and the chroma...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-08-3026

    authors: Chakraborty AA,Tansey WP

    更新日期:2009-01-01 00:00:00

  • Circulating tumor cell isolation and diagnostics: toward routine clinical use.

    abstract::From February 7-11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolation and Diagnostics: Toward Routine Clinical Use was held in Leiden (The Netherlands) to discuss progress and define challenges and potential solutions for development of clinically useful circulating tumor cell (CTC) d...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-11-1254

    authors: van de Stolpe A,Pantel K,Sleijfer S,Terstappen LW,den Toonder JM

    更新日期:2011-09-15 00:00:00

  • Extrahypothalamic mediation of changes in feeding behavior induced by growth of Walker 256 carcinosarcoma in rats.

    abstract::Feeding efficiency (amount of food ingested per unit of feeding activity) was chronically depressed in male Sprague-Dawley rats recovered from the acute aphagia or hypophagia of lateral hypothalamic damage. The extent of depression varied with the severity of the acute feeding response to hypothalamic damage. Growth o...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morrison SD

    更新日期:1981-05-01 00:00:00

  • Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells.

    abstract::Interactions between connective tissue substrates and proteinases localized to the surface of cancer cells are implicated in cancer invasion. In this report we have compared the enrichment of collagen and gelatin degrading activities and cysteine proteinase(s) in well-characterized (enzyme markers and electron microsc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zucker S,Wieman JM,Lysik RM,Wilkie D,Ramamurthy NS,Golub LM,Lane B

    更新日期:1987-03-15 00:00:00

  • Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.

    abstract::Galectin-1 (Gal1), an evolutionarily conserved glycan-binding protein, contributes to the creation of an immunosuppressed microenvironment at sites of tumor growth. In spite of considerable progress in elucidating its role in tumor-immune escape, the mechanisms underlying the inhibitory functions of Gal1 remain obscur...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2418

    authors: Dalotto-Moreno T,Croci DO,Cerliani JP,Martinez-Allo VC,Dergan-Dylon S,Méndez-Huergo SP,Stupirski JC,Mazal D,Osinaga E,Toscano MA,Sundblad V,Rabinovich GA,Salatino M

    更新日期:2013-02-01 00:00:00

  • Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.

    abstract::Previous electrophoretic analysis has indicated that keratins 13 and 16 (K13 and K16) are not present in normal human breast epithelium, but K16 is expressed in some ductal carcinomas (Moll et al., Cell, 31: 11-24, 1982). K16 may thus represent a marker for identifying a subset of ductal carcinomas and for distinguish...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pellegrino MB,Asch BB,Connolly JL,Asch HL

    更新日期:1988-10-15 00:00:00

  • High serum iron is associated with increased cancer risk.

    abstract::Epidemiologic studies linking high serum iron with cancer risks are limited and inconclusive, despite evidence implicating body iron in human carcinogenesis. A cohort of 309,443 adults in Taiwan who had no history of cancer had serum iron levels tested at the time of recruitment (1997-2008). Initially measured iron le...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0360

    authors: Wen CP,Lee JH,Tai YP,Wen C,Wu SB,Tsai MK,Hsieh DP,Chiang HC,Hsiung CA,Hsu CY,Wu X

    更新日期:2014-11-15 00:00:00

  • Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.

    abstract::Hexosaminidase activity in prostatic tissue has been compared in 15 patients with benign prostatic hyperplasia and 15 patients with prostatic carcinoma. The ratio of enzymatic activity for the two substrates tested (p-nitrophenyl-2-acetamido-2-deoxy-beta-D-glucopyranoside and p-nitrophenyl-2-acetamido-2-deoxy-beta-D-g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Whitehurst GB,Mashburn JP,Pretlow TG 2nd,Bradley EL Jr,Boohaker EA

    更新日期:1982-10-01 00:00:00

  • A common 8q24 variant in prostate and breast cancer from a large nested case-control study.

    abstract::Two recent studies independently identified polymorphisms in the 8q24 region, including a single nucleotide polymorphism (rs1447295), strongly associated with prostate cancer risk. Here, we replicate the overall association in a large nested case-control study from the National Cancer Institute Breast and Prostate Can...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3591

    authors: Schumacher FR,Feigelson HS,Cox DG,Haiman CA,Albanes D,Buring J,Calle EE,Chanock SJ,Colditz GA,Diver WR,Dunning AM,Freedman ML,Gaziano JM,Giovannucci E,Hankinson SE,Hayes RB,Henderson BE,Hoover RN,Kaaks R,Key T,Kol

    更新日期:2007-04-01 00:00:00

  • Multilaminar endoplasmic reticulum and abnormal mitosis in Hodgkin tumor cells.

    abstract::A multilaminar alteration of endoplasmic reticulum (ER) has been observed in tumor cells of eight patients with Hodgkin's disease and a patient with histiocytic lymphoma. These multilaminar structures are more numerous in dividing cells and thus appear to arise primarily during mitosis. The stacked membranes in the mu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parmley RT,Spicer SS,Garvin AJ

    更新日期:1976-05-01 00:00:00

  • Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3.

    abstract::We have previously reported that several biological agents, when given simultaneously with cytosine arabinoside or cytoxan, will protect from cytosine arabinoside-induced but not from cytoxan-induced alopecia. In the present study we used the secosteroid 1,25-dihydroxyvitamin D3 in a different timing schedule to prote...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Jimenez JJ,Yunis AA

    更新日期:1992-09-15 00:00:00

  • Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.

    abstract::A phenolic amine compound, 4-S-cysteaminylphenol (4-S-CAP), is a potent depigmenting agent. To develop more efficacious antimelanoma agents, we synthesized four homologues of 4-S-CAP: N-acetyl-4-S-CAP (N-Ac-4-S-CAP), alpha-methyl-4-S-CAP, 4-S-homo-CAP, and N,N'-dimethyl-4-S-CAP. We tested these five compounds in mice ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Alena F,Jimbow K,Ito S

    更新日期:1990-06-15 00:00:00